Revenue + Forward P/E
BeOne Medicines AG (ONC) quarterly revenue and forward P/EForward P/E: 45.7x
RevenueRevenue (est)Forward P/E
Fair value & valuation models
Fair value models are a Plus feature
Upgrade to Plus for the interactive DCF model, valuation bands, and implied-price scenarios.
71% OFF$23.99 $6.99/mo
Ends in23:59:59
Cancel anytime. Secure checkout via Stripe.
Valuation
Market cap
$38.13B
Enterprise value
$39.65B
P/E ratio (TTM)
5.05x
P/S ratio (TTM)
7.36x
P/B ratio
12.25x
EV/Sales
6.87x
EV/EBITDA
47.08x
Dividend yield
0.00%
Income statement (TTM)
Revenue (TTM)
$5.34B
Gross profit (TTM)
$4.67B
Operating income (TTM)
$447.14M
EBITDA (TTM)
$616.77M
Net income (TTM)
$286.93M
Free cash flow (TTM)
$941.74M
Margins & returns
Gross margin
87.17%
Operating margin
11.96%
Profit margin
8.93%
Return on equity
12.10%
Return on assets
6.00%
Per-share metrics
EPS (TTM)
$4.64
Dividend yield
0.00%
Beta
0.49
Capital structure
Cash & equivalents
$4.55B
Total debt
$2.00B
Net debt
$-2.55B
Shares outstanding
106.86M
Financial health
Current ratio
3.41
Debt / equity
0.46
Debt / assets
0.24
Interest coverage
7.68
| Company | Market cap | P/E | P/S | EV/EBITDA | Div yield |
|---|---|---|---|---|---|
| $1.15T | 42.41x | 15.59x | 34.80x | 0.54% | |
| $629.74B | 30.45x | 6.47x | 20.76x | 1.99% | |
| $442.63B | 127.13x | 7.29x | 30.82x | 2.63% | |
| $365.71B | 27.06x | 0.85x | 16.46x | 2.13% | |
| $355.30B | 23.91x | 4.80x | 15.14x | 2.67% | |
| $332.76B | 36.82x | 4.94x | 19.57x | 2.56% | |
| $38.13B | 5.05x | 7.36x | 47.08x | - |